CDC reports on vaccine effectiveness of bivalent COVID-19 vaccine among vaccinated vs. unvaccinated adults aged ≥65 years in 2022-23

The designation is aimed at speeding up the development and review of drugs for serious conditions. Credit: skipper_sr/Shutterstock. The US Food and Drug Administration (FDA)

As the FDA and oth­er reg­u­la­tors look to stream­line the de­vel­op­ment of new biosim­i­lars fur­ther, the US agency is look­ing to in­still in its for­eign